Worth the weight? What Hongkongers should know about slimming injections

South China Morning PostCenter-RightEN 1 min read 100% complete by Fiona SunJanuary 25, 2026 at 03:30 AM

AI Summary

short article 1 min

A recent study revealed that nearly half of Hong Kong residents are overweight or obese, leading to increased interest in weight-loss injections. The *Hong Kong Post* investigated the availability of these prescription-only medications, such as Wegovy, Ozempic, Saxenda, and Mounjaro, and found them being sold online and in pharmacies without proper doctor's approval. These injections, which mimic the GLP-1 hormone to suppress appetite, are approved in Hong Kong to treat obesity, a growing concern due to its association with diseases like diabetes and cardiovascular issues. The investigation raises concerns about potential health risks associated with obtaining these medications without medical supervision.

Key Entities & Roles

Key Player Opposition Context

United States 40% Denmark 40% Mounjaro 70% Ozempic 70% Saxenda 70% Wegovy 70% Novo Nordisk 80% Eli Lilly 80% Hong Kong ×390%

Keywords

weight-loss injections 100% hong kong 90% obesity 80% prescription-only medicines 70% health risks 60% appetite suppressants 60% wegovy 50% ozempic 50% glp-1 50% cardiovascular diseases 40%